Loading clinical trials...
Loading clinical trials...
TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH and related conditions across the entire spectrum NAFLD in usual clinical practice. TARGET-NASH is a researc...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Target PharmaSolutions, Inc.
NCT03587831 · NASH - Nonalcoholic Steatohepatitis
NCT07518784 · MASLD, MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), and more
NCT07237750 · Overweight and/or Obesity, Metabolic Syndrome, and more
NCT06318169 · Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
NCT05842512 · Nonalcoholic Steatohepatitis (NASH)
Banner University Medical Center - Phoenix Transplant Center and Advanced Liver Clinic
Phoenix, Arizona
Stanford University
Palo Alto, California
California Liver Research Institute
Pasadena, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions